The role of pentraxin-3 as a prognostic biomarker in paraquat poisoning

Toxicology Letters

Volumn 212, Issue 2, 2012, Pages 157-160

  Yeo, Chang Dong ^a,b   Kim, Jin Woo ^a,b   Kim, Young Ok ^a,b   Yoon, Sun Ae ^a,b   Kim, Kwan Hyoung ^a,b   Kim, Young Soo ^a,b  

^a Uijeongbu St Mary's Hospital   (South Korea)

^b NONE   (South Korea)

Author keywords

Lung injury; Paraquat; Prognosis; PTX3 protein

Indexed keywords

BIOLOGICAL MARKER; EDETIC ACID; PARAQUAT; PENTRAXIN 3;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOPERFUSION; HUMAN; LUNG FIBROSIS; MALE; OUTCOME ASSESSMENT; PARAQUAT POISONING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SOLID; SURVIVAL; SURVIVOR;

EID: 84861869252     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.12.007     Document Type: Article

References (35)

1. Biagi E., Col M., Migliavacca M., Dell'Oro M., Silvestri D., Montanelli A., Peri G., Mantovani A., Biondi A., Rossi M.R. PTX3 as a potential novel tool for the diagnosis and monitoring of pulmonary fungal infections in immuno-compromised pediatric patients. J. Pediatr. Hematol. Oncol. 2008, 30:881-885.
2. Bismuth C., Garnier R., Dally S., Fournier P.E., Scherrmann J.M. Prognosis and treatment of paraquat poisoning: a review of 28 cases. J. Toxicol. Clin. Toxicol. 1982, 19:461-474.
3. Boehme M., Kaehne F., Kuehne A., Bernhardt W., Schröder M., Pommer W., Fischer C., Becker H., Müller C., Schindler R. Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease. Nephrol. Dial. Transplant. 2007, 22:2224-2229.
4. Candan F., Alagozlu H. Captopril inhibits the pulmonary toxicity of paraquat in rats. Hum. Exp. Toxicol. 2001, 20:637-641.
5. Clark D.G., McElligott T.F., Hurst E.W. The toxicity of paraquat. Br. J. Ind. Med. 1966, 23:126-132.
6. Dinis-Oliveira R.J., Duarte J.A., Sanchez-Navarro A., Remiao F., Bastos M.L., Carvalho F. Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit. Rev. Toxicol. 2008, 38:13-71.
7. Eddleston M. Patterns and problems of deliberate self-poisoning in the developing world. QJM 2000, 93:715-731.
8. Fukuda Y., Ferrans V.J., Schoenberger C.I., Rennard S.I., Crystal R.G. Patterns of pulmonary structural remodeling after experimental paraquat toxicity. The morphogenesis of intraalveolar fibrosis. Am. J. Pathol. 1985, 118:452-475.
9. Gando S., Nanzaki S., Morimoto Y., Kobayashi S., Kemmotsu O. Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis. J. Trauma 1999, 47:719-723.
10. Garlanda C., Bottazzi B., Bastone A., Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu. Rev. Immunol. 2005, 23:337-366.
11. Gil H.-W., Kang M.-S., Yang J.-O., Lee E.-Y., Hong S.-Y. Association between plasma paraquat level and outcome of paraquat poisoning in 375 paraquat poisoning patients. Clin. Toxicol. 2008, 46:515-518.
12. Gil H.W., Hong J.R., Park J.H., Seo Y.S., Yang J.O., Lee E.Y., Hong S.Y. Plasma surfactant D in patients following acute paraquat intoxication. Clin. Toxicol. (Phila.) 2007, 45:463-467.
13. Han B., Haitsma J.J., Zhang Y., Bai X., Rubacha M., Keshavjee S., Zhang H., Liu M. Long pentraxin PTX3 deficiency worsens LPS-induced acute lung injury. Intens. Care Med. 2011, 37:334-342.
14. Hart T.B. Paraquat - a review of safety in agricultural and horticultural use. Hum. Toxicol. 1987, 6:13-18.
15. Hart T.B., Nevitt A., Whitehead A. A new statistical approach to the prognostic significance of plasma paraquat concentrations. Lancet 1984, 2:1222-1223.
16. He X., Han B., Bai X., Zhang Y., Cypel M., Mura M., Keshavjee S., Liu M. PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation. Intens. Care Med. 2010, 36:356-364.
17. He X., Han B., Liu M. Long pentraxin 3 in pulmonary infection and acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L1039-L1049.
18. Honore P., Hantson P., Fauville J.P., Peeters A., Manieu P. Paraquat poisoning, "state of the art" Acta Clin. Belg. 1994, 49:220-228.
19. Huttunen R., Hurme M., Aittoniemi J., Huhtala H., Vuento R., Laine J., Jylhava J., Syrjanen J. High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort study. PLoS One 2011, 6:e17653.
20. Jylhava J., Haarala A., Kahonen M., Lehtimaki T., Jula A., Moilanen L., Kesaniemi Y.A., Nieminen M.S., Hurme M. Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey. Clin. Exp. Immunol. 2011, 164:211-217.
21. Kaess B.M., Vasan R.S. Heart failure: pentraxin 3-a marker of diastolic dysfunction and HF?. Nat. Rev. Cardiol. 2011, 8:246-248.
22. Kao C.H., Hsieh J.F., Ho Y.J., Hung D.Z., Lin T.J., Ding H.J. Acute paraquat intoxication: using nuclear pulmonary studies to predict patient outcome. Chest 1999, 116:709-714.
23. Kume N., Mitsuoka H., Hayashida K., Tanaka M. Pentraxin 3 as a biomarker for acute coronary syndrome: comparison with biomarkers for cardiac damage. J. Cardiol. 2011, 58:38-45.
24. Latini R., Maggioni A.P., Peri G., Gonzini L., Lucci D., Mocarelli P., Vago L., Pasqualini F., Signorini S., Soldateschi D., Tarli L., Schweiger C., Fresco C., Cecere R., Tognoni G., Mantovani A. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004, 110:2349-2354. on behalf of the Lipid Assessment Trial Italian Network Investigators.
25. Li L.R., Sydenham E., Chaudhary B., You C. Glucocorticoid with cyclophosphamide for paraquat-induced lung fibrosis. Cochrane Database Syst. Rev. 2010, CD008084.
26. Mauri T., Coppadoro A., Bellani G., Bombino M., Patroniti N., Peri G., Mantovani A., Pesenti A. Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity. Crit. Care Med. 2008, 36:2302-2308.
27. Muller B., Peri G., Doni A., Torri V., Landmann R., Bottazzi B., Mantovani A. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit. Care Med. 2001, 29:1404-1407.
28. Napoleone E., Di Santo A., Bastone A., Peri G., Mantovani A., de Gaetano G., Donati M.B., Lorenzet R. Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation. Arterioscler. Thromb. Vasc. Biol. 2002, 22:782-787.
29. Napoleone E., di Santo A., Peri G., Mantovani A., de Gaetano G., Donati M.B., Lorenzet R. The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation. J. Leukoc. Biol. 2004, 76:203-209.
30. Okutani D., Han B., Mura M., Waddell T.K., Keshavjee S., Liu M. High-volume ventilation induces pentraxin 3 expression in multiple acute lung injury models in rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L144-L153.
31. Savchenko A.S., Inoue A., Ohashi R., Jiang S., Hasegawa G., Tanaka T., Hamakubo T., Kodama T., Aoyagi Y., Ushiki T., Naito M. Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis. Pathol. Int. 2011, 61:290-297.
32. Senarathna L., Eddleston M., Wilks M.F., Woollen B.H., Tomenson J.A., Roberts D.M., Buckley N.A. Prediction of outcome after paraquat poisoning by measurement of the plasma paraquat concentration. QJM 2009, 102:251-259.
33. Smith P., Heath D. Paraquat. CRC Crit. Rev. Toxicol. 1976, 4:411-445.
34. Suliman M.E., Qureshi A.R., Carrero J.J., Barany P., Yilmaz M.I., Snaedal-Jonsdottir S., Alvestrand A., Heimburger O., Lindholm B., Stenvinkel P. The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality. QJM 2008, 101:397-405.
35. Suntres Z.E. Role of antioxidants in paraquat toxicity. Toxicology 2002, 180:65-77.